<DOC>
	<DOCNO>NCT01008540</DOCNO>
	<brief_summary>The investigator aim determine incidence cytomegalovirus resistance antiviral cohort study . The patient include first CMV active infection follow two year thereafter . When criterion suspect resistance meet , blood urine sample collect virus isolation resistance phenotype , resistance genotype determination . Results compare baseline sample . Clinical information treatment , immunosuppressive regimen clinical evolution collect . Through study , investigator aim organize national network detection identification CMV resistant strain useful new therapeutic available .</brief_summary>
	<brief_title>Prospective Multicentric Study Cytomegalovirus Resistance Transplant Patients Bone Marrow Recipients</brief_title>
	<detailed_description />
	<criteria>Allogeneic bone marrow transplant recipient solid organ transplant recipient , include cohort time fir active CMV infection ( ie biological sign CMV replication ( viremia , ADN ARN aemia , Antigenaemiapp65… . ) without fever , clinical end organ disease symptom Patient without medical care.policy , patient sign médical consent</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>cytomegalovirus</keyword>
	<keyword>resistance</keyword>
	<keyword>transplantation</keyword>
	<keyword>Patient come French transplantation center solid organ bone marrow transplant , information sign consent</keyword>
</DOC>